Abstract
When it comes to medical decisions, people have to deal with a wide range of information from different sources. Information from the media is a prominent example: It increasingly addresses health-related issues and communicates benefits and risks of medical treatments and prevention programs. Is the media a reliable and objective source of health information? To investigate this issue, we conducted a media analysis of the widely promoted vaccination against human papillomavirus (HPV) in newspaper reports and Internet sources in Germany and Spain. These two countries differ in vaccination compliance rates and in the extent to which their health systems are directive. This chapter describes information categories in the media analyses. These categories included prevalence of cervical cancer and risk at baseline of suffering this disease, etiology, effectiveness of the vaccination, possible side effects, and costs. We compared media coverage and how balanced reports were in the two countries and investigated cross-cultural differences in medical communication.
In this chapter, we partially reproduce the article Bodemer, N., Müller, S. M., Okan, Y., Garcia-Retamero, R., & Neumeyer-Gromen, A. (2012). Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine. Vaccine, 30, 3747–3756.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
The vaccine by Gardasil® protects against HPV 16 and 18, which have been found in 70% of all cervical cancers (Zechmeister et al. 2007).
- 2.
Follow-up studies that provide data to allow an evaluation of the vaccine’s effectiveness in reducing cervical cancer incidence and mortality are not yet available; cancer development needs decades of observation.
References
Abdelmutti, N., & Hoffman-Goetz, L. (2009). Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: A content analysis of Canadian and U.S. national newspaper articles. Women and Health, 49, 422–440.
Bodemer, N., Müller, S. M., Okan, Y., Garcia-Retamero, R., & Neumeyer-Gromen, A. (2012). Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine. Vaccine, 30, 3747–3756.
Brun, W., & Teigen, K. H. (1988). Verbal probabilities: Ambiguous, context-dependent, or both? Organizational Behavior and Human Decision Processes, 41, 390–404.
Budescu, D. V., & Wallsten, T. S. (1985). Consistency in interpretation of probabilistic phrases. Organizational Behavior and Human Decision Processes, 36, 391–405.
Commission, E. (1998). A guideline on the readability of the label and package leaflet of medicinal products for human use. Brussels: EC Pharmaceuticals Committee.
Consolidated Standards of Reporting Trials (CONSORT) (2011). http://www.consort-statement.org/consort-statement/, accessed July 30, 2012.
Cotton, S. R., & Gupta, S. S. (2004). Characteristics of online and offline health information seekers and factors that discriminate between them. Social Science and Medicine, 59, 1795–1806.
Coulter, A., & Jenkins, C. (2005). European patients’ views on the responsiveness of health systems and healthcare providers. European Journal of Public Health, 15, 355–360.
Delgado, A., López-Fernández, L. A., de Dios Luna, J., Saletti Cuesta, L., Gil Garrido, N., & Puga González, A. (2010). Patient expectation of decision making for distinct health problems. Gaceta Sanitaria, 24, 66–71.
Dören, M., Gerhardus, A., Gerlach, F. M., Hornberg, C., Kochen, M. M., Kolip, P., et al. (2008). Wissenschaftlier/innen fordern Neubewertung der HPV-Impfung und ein Ende der irreführenden Informationen [Scientists request a re-evaluation of the HPV vaccination and an end to providing misleading information]. http://www.uni-bielefeld.de/gesundhw/ag3/downloads/Stellungnahme_Wirksamkeit_HPV-Impfung.pdf, accessed July 30, 2012.
Edwards, A., & Elwyn, G. (2009). Shared decision making in health care: Achieving evidence-based patient choice. Oxford: Oxford University Press.
Elwyn, G. J., O’Connor, A., Stacey, D., Volk, R., Edwards, A. G. K., Coulter, A., et al. (2006). Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process. British Medical Journal, 333, 417–424.
European Medicines Agency (2008a). Committee for medical products for human use post-authorisation summary of positive opinion for Silgard. http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/000732/WC500059444.pdf, accessed July 30, 2012.
European Medicines Agency (2008b). Europ. Beurteilungsbericht [European evaluation report] (EPAR) GARDASIL (31/10/2008 Gardasil-H-C-703- II-13). http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000703/human_med_000805.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp, accessed July 30, 2012 and http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/000703/WC500021147.pdf, accessed July 9, 2012.
Fricke, A. (2010). Langfristiger Erfolg der HPV Impfung erwartet [Long-term success of the HPV vaccination expected]. Ärztezeitung [Doctors’ journal]. http://www.aerztezeitung.de/politik_gesellschaft/article/592205/langfristiger-erfolg-hpv-impfung-erwartet.html, accessed July 30, 2012.
Frost, K., Frank, E., & Maibach, E. (1997). Relative risk in the news media: A quantification of misrepresentation. American Journal of Public Health, 87, 842–845.
Future, I. Investigators. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. The New England Journal of Medicine, 356, 1928–1943.
Future, II Study Group. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. The New England Journal of Medicine, 356, 1915–1927.
Gigerenzer, G., Gaissmaier, W., Kurz-Milcke, E., Schwartz, L. M., & Woloshin, S. (2007). Helping doctors and patients to make sense of health statistics. Psychological Science in the Public Interest, 8, 53–96.
Gigerenzer, G., & Gray, M. (2011). Launching the century of the patient. In G. Gigerenzer & M. Gray (Eds.), Better doctors, better patients, better decisions: Envisioning health care 2020 (pp. 3–28). Cambridge, MA: MIT Press.
Grilli, R., Ramsey, C., & Minozzi, S. (2009). Mass media interventions: Effects on health care utilization. Cochrane Database Systematical Review, 1, CD000389.
Habel, M. A., Liddon, N., & Stryker, J. E. (2009). The HPV vaccine: A content analysis of online news stories. Journal of Women’s Health, 18, 401–407.
Holmes-Rovner, M. (2007). International Patient Decision Aid Standards (IPDAS): Beyond decision aids to usual design of patient education materials. Health Expectation, 10, 103–107.
James, C., James, N., Davies, D., Harvey, P., & Tweddle, S. (1999). Preferences for different sources of information about cancer. Patient Education and Counseling, 37, 273–282.
Johnson, J. (1997). Cancer-related information seeking. Cresskill, NJ: Hampton Press.
Kelly, B. J., Leader, A. E., Mittermaier, D. J., Hornik, R. C., & Cappella, J. N. (2009). The HPV vaccine and the media: How has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Education and Counseling, 77, 308–313.
Knapp, P., Raynor, D. K., & Berry, D. C. (2004). Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality and Safety in Health Care, 13, 176–180.
Kurzenhäuser, S. (2003). Welche Informationen vermitteln deutsche Gesundheitsbroschüren über die Screening-Mammographie [What information is provided by German health brochures about mammography screening]? Zeitschrift für Ärztliche Fortbildung und Qualitätssicherung, 97, 53–57.
Martín-Llaguno, M., & Álvarez-Dardet, C. (2010). Withdrawal of an advertising campaign to promote the quadrivalent human papilloma virus vaccine in Spain. Gaceta Sanitaria, 24, 75–77.
Meissner, H. I., Potosky, A. L., & Convissor, R. (1992). How sources of health information relate to knowledge and use of cancer screening exams. Journal of Community Health, 17, 153–165.
Ministerio de Sanidad, Politica Social e Igualidad (2011). Coberturas de vacunación (vaccination coverage). http://www.msps.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm, accessed July 30, 2012.
Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., et al. (2000). Coverage by the news media of the benefits and risks of medications. The New England Journal of Medicine, 342, 1645–1650.
Neumeyer-Gromen, A., Bodemer, B., Müller, S. M., & Gigerenzer, G. (2011). Ermöglichen Medienberichte und Broschüren informierte Entscheidungen zur Gebärmutterhalskrebsprävention? [Do media reports and brochures facilitate decisions about prevention of cervical cancer?]. Bundesgesundheitsblatt, 54, 1197–1210.
O’Connor, A. M., Bennett, C., Stacey, D., Barry, M. J., Col, N. F., Eden, K. B., et al. (2007). Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Medical Decision Making, 27, 554–574.
Sanofi Pasteur MSD GmbH (2010). Tell someone. Eine Informationsseite über Gebärmutterhalstkrebs, seine Vorstufen und die HPV-Impfung (An information site about cervical cancer, its preliminary stages and the HPV vaccination). http://www.tellsomeone.de/, accessed July 30, 2012.
Sarfati, D., Howden-Chapman, P., Woodward, A., & Salmond, C. (1998). Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed. Journal of Medical Screening, 5, 137–140.
Schönbach, K., de Waal, E., & Lauf, E. (2005). Online and print newspapers: Their impact on the extent of the perceived public agenda. European Journal of Communication, 20, 245–258.
Schwartz, G. G., Olsson, A. G., Ezekowitz, M. D., Ganz, P., Oliver, M. F., Waters, D., et al. (2001). Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial. Journal of the American Medical Association, 285, 1711–1718.
Schwartz, L. M., Woloshin, S., & Welch, H. G. (2009). Using a drug facts box to communicate drug benefits and harms. Annals of Internal Medicine, 150, 516–527.
Steckelberg, A., Balgenorth, A., & Mühlhauser, I. (2001). Analyse von deutschsprachigen Verbraucher-Informationsbroschüren zum Screening auf kolorektales Karzinom [An analysis of German consumer-information brochures about the screening of colorectal cancer]. Zeitschrift für Ärztliche Fortbildung und Qualitätssicherung, 95, 535–538.
Steurer, J., Held, U., Schmidt, M., Gigerenzer, G., Tag, B., & Bachman, L. M. (2009). Legal concerns trigger PSA testing. Journal of Evaluation in Clinical Practice, 15, 390–392.
Strobe Statement (2011). Strengthening the reporting of observational studies in epidemiology. http://www.strobe-statement.org/, accessed July 30, 2012.
Studdert, D. M., Mello, M. M., Sage, W. M., DesRoches, C. M., Peugh, J., Zapert, K., et al. (2005). Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. Journal of the American Medical Association, 293, 2609–2617.
Weinfurt, K. P., Seils, D. M., Tzeng, J. P., Lin, L., Schulman, K. A., & Califf, R. M. (2008). Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS One, 7, e2128.
World Health Organization (2011). Preparing for the introduction of HPV vaccine in the WHO European region. http://www.euro.who.int/__data/assets/pdf_file/0007/98746/E91432.pdf, accessed July 9, 2012.
World Health Organization (2012). World Health Statistics 2012. http://www.who.int/gho/publications/world_health_statistics/2012/en/, accessed July 30, 2012.
Zechmeister, I., Freiesleben de Blasio, B., Radlberger, P., Wild, C., Kvas, E., Garnett, G., et al. (2007). Ökonomische Evaluation der Impfung gegen humane Papillomaviren (HPV-Impfung) in Österreich. HTA-Projektbericht Nr. 009, Wien 2007. [Economic evaluation of the vaccination against human papillomavirus (HPV vaccination) in Austria. HTA project report no. 009, Vienna 2007]. http://eprints.hta.lbg.ac.at/760/2/HTA-Projektbericht_009.pdf, accessed July 30, 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Müller, S.M., Bodemer, N., Okan, Y., Garcia-Retamero, R., Neumeyer-Gromen, A. (2012). Transparent Health Information in the Media. In: Garcia-Retamero, R., Galesic, M. (eds) Transparent Communication of Health Risks. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4358-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4358-2_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4357-5
Online ISBN: 978-1-4614-4358-2
eBook Packages: MedicineMedicine (R0)